Expression of cyclooxygenase-2 in choroidal neovascular membranes from age-related macular degeneration patients

Retina

Volumn 29, Issue 2, 2009, Pages 176-180

  Maloney, Shawn C ^a   Fernandes, Bruno F ^a   Castiglione, Enzo ^a   Antecka, Emilia ^a   Martins, Claudia ^a   Marshall, Jean Claude ^a   Di Cesare, Sebastian ^a   Logan, Patrick ^a   Burnier Jr , Miguel N ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; PARAFFIN; VIMENTIN; VISUAL PIGMENT;

ADULT; AGED; ANTIGENICITY; ARTICLE; CHOROID VASCULARIZATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA MACULA AGE RELATED DEGENERATION; TISSUE SECTION; VASCULAR ENDOTHELIUM; ENZYME IMMUNOASSAY; ENZYMOLOGY; MEMBRANE; METABOLISM; MIDDLE AGED; RETINA MACULA DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; CYCLOOXYGENASE 2; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLASTS; HUMANS; IMMUNOENZYME TECHNIQUES; MACULAR DEGENERATION; MALE; MEMBRANES; MIDDLE AGED; RETINAL PIGMENT EPITHELIUM; VIMENTIN;

EID: 63249116911     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181884fa6     Document Type: Article

References (24)

1. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J 1998;12:1063-1073.
2. Skold M, Cullheim S, Hammarberg H, et al. Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur J Neurosci 2000;12:3675-3686.
3. Takahashi H, Yanagi Y, Tamaki Y, Uchida S, Muranaka K. COX-2-selective inhibitor, etodolac, suppresses choroidal neo-vascularization in a mice model. Biochem Biophys Res Commun 2004;325:461-466.
4. Takahashi K, Saishin Y, Saishin Y, et al. Topical nepafenac inhibits ocular neovascularization. Invest Ophthalmol Vis Sci 2003;44:409-415.
5. Yamada M, Kawai M, Kawai Y, Mashima Y. The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat. Curr Eye Res 1999;19:300-304.
6. Ayalasomayajula SP, Kompella UB. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model. Eur J Pharmacol 2003; 458:283-289.
7. Wilkinson-Berka JL, Alousis NS, Kelly DJ, Gilbert RE. COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2003; 44:974-979.
8. Ju WK, Neufeld AH. Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina. J Comp Neurol 2002;452:392-399.
9. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The blue mountains eye study. Ophthalmology 1995;102:1450-1460.
10. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The beaver dam eye study. Ophthalmology 1992;99:933-943.
11. Chin MS, Nagineni CN, Hooper LC, Detrick B, Hooks JJ. Cyclooxygenase-2 gene expression and regulation in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2001;42:2338-2346.
12. Ershov AV, Bazan NG. Induction of cyclooxygenase-2 gene expression in retinal pigment epithelium cells by photoreceptor rod outer segment phagocytosis and growth factors. J Neurosci Res 1999;58:254-261.
13. Gilroy DW, Saunders MA, Wu KK. COX-2 expression and cell cycle progression in human fibroblasts. Am J Physiol Cell Physiol 2001;281:C188-C194.
14. Parfenova H, Parfenov VN, Shlopov BV, et al. Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells. Am J Physiol Cell Physiol 2001;281:C166-C178.
15. Wu G, Mannam AP, Wu J, et al. Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF. Am J Physiol Heart Circ Physiol 2003;285:H2420- H2429.
16. Tong JP, Yao YF. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin Biochem 2006;39:267-276.
17. Hu W, Criswell MH, Ottlecz A, et al. Oral administration of lumiracoxib reduces choroidal neovascular membrane development in the rat laser-trauma model. Retina 2005;25:1054- 1064.
18. Amrite AC, Kompella UB. Celecoxib inhibits proliferation of retinal pigment epithelial and choroid-retinal endothelial cells by a cyclooxygenase-2-independent mechanism. J Pharmacol Exp Ther 2008;324:749-758.
19. Kang KB, Van Der Zypp A, Iannazzo L, Majewski H. Agerelated changes in monocyte and platelet cyclooxygenase expression in healthy male humans and rats. Transl Res 2006; 148:289-294.
20. Matz RL, de Sotomayor MA, Schott C, Stoclet JC, Andriantsitohaina R. Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol 2000;131:303-311.
21. Heymes C, Habib A, Yang D, et al. Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing. Br J Pharmacol 2000;131:804-810.
22. Kim JW, Baek BS, Kim YK, et al. Gene expression of cyclooxygenase in the aging heart. J Gerontol A Biol Sci Med Sci 2001;56:B350-B355.
23. Chung HY, Kim HJ, Shim KH, Kim KW. Dietary modulation of prostanoid synthesis in the aging process: role of cycloox-ygenase-2. Mech Ageing Dev 1999;111:97-106.
24. Leung WK, To KF, Go MY, et al. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angio-genesis in human gastric carcinoma. Int J Oncol 2003;23: 1317-1322.